Heparin-induced thrombocytopenia in myeloproliferative disorders: A rare or under-diagnosed complication?

American Journal of Hematology

Volumn 83, Issue 5, 2008, Pages 420-423

  Spectre, Galia ^a   Kalish, Yossi ^a   Schliamser, Liliana ^b   Varon, David ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b BNAI ZION MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DANAPAROID; DRUG ANTIBODY; ENOXAPARIN; FOLIC ACID; HEPARIN; HEPARIN INDUCED THROMBOCYTOPENIA ANTIBODY; WARFARIN;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CASE REPORT; DOSE TIME EFFECT RELATION; FEMALE; GASTROINTESTINAL HEMORRHAGE; GENDER; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; IMMUNOASSAY; MYELOPROLIFERATIVE DISORDER; PARTICLE GEL IMMUNOASSAY; POLYCYTHEMIA VERA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RISK FACTOR; SKIN NECROSIS; THROMBOCYTE COUNT; THROMBOCYTHEMIA; THROMBOCYTOPENIA; THROMBOSIS;

AGED; ANTICOAGULANTS; CARCINOMA; CATHETERIZATION, CENTRAL VENOUS; FALSE NEGATIVE REACTIONS; FEMALE; HEPARIN; HUMANS; MALE; MIDDLE AGED; PLATELET COUNT; PLATELET FACTOR 4; POLYCYTHEMIA VERA; POSTOPERATIVE COMPLICATIONS; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RISK FACTORS; THROMBOCYTHEMIA, HEMORRHAGIC; THROMBOPHILIA; UTERINE CERVICAL NEOPLASMS; VENOUS THROMBOSIS;

EID: 42949153260     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21128     Document Type: Article

References (25)

1. Greinacher A, Warkentin TE. Recognition, treatment, and prevention of heparin-induced thrombocytopenia: Review and update. Thromb Res 2006; 118: 165-176.
2. Warkentin TE, Levine MN, Hirsh J, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 1995;332:1330-1335.
3. Demasi R, Bode AP, Knupp C, et al. Heparin-induced thrombocytopenia. Am Surg 1994;60:26-29.
4. Schmitt BP, Adelman B. Heparin-associated thrombocytopenia: A critical review and pooled analysis. Am J Med Sci 1993;305:208-215.
5. Harbrecht U, Bastians B, Kredteck A, et al. Heparin-induced thrombocytopenia in neurologic disease treated with unfractionated heparin. Neurology 2004;62:657-659.
6. Walenga JM, Jeske WP, Prechel MM, et al. Decreased prevalence of heparin-induced thrombocytopenia with low-molecular-weight heparin and related drugs. Semin Thromb Hemost 2004;Suppl 1:69-80.
7. Prandoni P, Siragusa S, Girolami B, et al. The incidence of heparin-induced thrombocytopenia in medical patients treated with low-molecular-weight heparin: A prospective cohort study. Blood 2005;106:3049-3054.
8. Warkentin TE. Clinical presentation of heparin induced thrombocytopenia. Semin Hematol 1998;35:9-16.
9. Gruppo Italiano Studio Policitemia. Polycythemia Vera. The Natural History of 1213 Patients Followed for 20 Years. Ann Inter Med 1995;123:656-664.
10. Walther EU, Tiecks FP, Haberl RL. Cranial sinus thrombosis associated with essential thrombocythemia followed by heparin-associated thrombocytopenia. Neurology 1996;47:300-301.
11. Risch L, Pihan H, Zeller C, Huber AR. ET gets HIT- thrombocytotic heparin-induced thrombocytopenia (HIT) in a patient with essential thrombocythemia (ET). Blood Coagul Fibrinolysis 2000;11:663-667.
12. Houston DS. Heparin-induced thrombocytopenia without thrombocytopenia in a patient with essential thrombocythemia. Am J Hematol 2000;65:331-332.
13. Garcia S, Cervero A, Sanchez M, Colomina P. Heparin-associated thrombocytopenia in a patient with polycythemia vera: The importance of a marked drop in platelet count. Acta Haematol 1991;85:169-170.
14. Hayashi T, Suyama Y, Kaneko M, et al. Heparin-induced thrombocytopenia and thrombosis in a patient with polycythemia vera. Inter Med 2004;43:587-589.
15. Kyritsis AP, Williams EC, Schutta HS. Cerebral venous thrombosis due to heparin induced thrombocytopenia. Stroke 1990;21:1503-1505.
16. Falanga A, Marchetti M, Evangelista V, et al. Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia vera. Blood 2000;96:4261-4266.
17. Warkentin TE, Kelton JG. Delayed-onset heparin-induced thrombocytopenia and thrombosis. Ann Intern Med 2001;135:502-506.
18. Carlsson LE, Lubenow N, Blumentritt C, et al. Platelet receptor and clotting factor polymorphisms as genetic risk factors for thromboembolic complications in heparin-induced thrombocytopenia. Pharmacogenetics 2003;13:253-258.
19. Lee DH, Warkentin TE, Denomme GA, et al. Factor V Leiden and thrombotic complications in heparin-induced thrombocytopenia. Thromb Haemost 1998;79:50-53.
20. Warkentin TE, Roberts RS, Hirsh J, Kelton JG. An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients. Arch Intern Med 2003;163:2518-2524.
21. Hach-Wunderle V, Kainer K, Salzmann G, et al. Heparin-related thrombosis despite normal platelet counts in vascular surgery. Am J Surg 1997;173:117-119.
22. Risch L, Fischer JE, Schmugge M, Huber AR. Association of anti-heparin platelet factor 4 antibody levels and thrombosis in pediatric intensive care patients without thrombocytopenia. Blood Coagul Fibrinolysis 2003;14:113-116.
23. Warkentin TE, Sheppard JA, Sigouin CS, et al. Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia. Blood 2006;108:2937-2941.
24. Warkentin TE. Think of HIT. Hematology Am Soc Hematol Educ Program 2006;1:408-414.
25. Martel N, Lee J, Wells PS. Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: A meta-analysis. Blood 2005;106:2710-2715.